Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Jackson

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2017
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan AllograftsKile Green, Kim Pearce, Rob S Sellar, et al.
British Journal of Haematology|May 5, 2022
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosisSriram Ravichandran, Shameem Mahmood, Brenden Wisniowski, et al.
British Journal of Haematology|July 30, 2015
Time to redefine MyelomaGuy Pratt, Stella Bowcock, Andrew Chantry, et al.
Blood Cancer Journal|January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic reviewHira Mian, Arleigh McCurdy, Smith Giri, et al.
Blood|January 21, 2006
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontaminationErnst Holler, Gerhard Rogler, Julia Brenmoehl, et al.
Blood|December 23, 2022
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trialAikaterini Panopoulou, David A Cairns, Amy Holroyd, et al.
Oncotarget|April 14, 2017
Search for rare protein altering variants influencing susceptibility to multiple myelomaMatthew Scales, Daniel Chubb, Sara E Dobbins, et al.
Nature Communications|March 29, 2018
Ikaros family zinc finger 1 regulates dendritic cell development and function in humansUrszula Cytlak, Anastasia Resteu, Delfien Bogaert, et al.
Blood Cancer Journal|August 12, 2024
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigmCharlotte Pawlyn, Fredrik H Schjesvold, David A Cairns, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2017
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan AllograftsKile Green, Kim Pearce, Rob S Sellar, et al.
British Journal of Haematology|May 5, 2022
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosisSriram Ravichandran, Shameem Mahmood, Brenden Wisniowski, et al.
British Journal of Haematology|July 30, 2015
Time to redefine MyelomaGuy Pratt, Stella Bowcock, Andrew Chantry, et al.
Blood Cancer Journal|January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic reviewHira Mian, Arleigh McCurdy, Smith Giri, et al.
Blood|January 21, 2006
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontaminationErnst Holler, Gerhard Rogler, Julia Brenmoehl, et al.
Blood|December 23, 2022
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trialAikaterini Panopoulou, David A Cairns, Amy Holroyd, et al.
Oncotarget|April 14, 2017
Search for rare protein altering variants influencing susceptibility to multiple myelomaMatthew Scales, Daniel Chubb, Sara E Dobbins, et al.
Nature Communications|March 29, 2018
Ikaros family zinc finger 1 regulates dendritic cell development and function in humansUrszula Cytlak, Anastasia Resteu, Delfien Bogaert, et al.
Blood Cancer Journal|August 12, 2024
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigmCharlotte Pawlyn, Fredrik H Schjesvold, David A Cairns, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Pageof 26